Per- and polyfluoroalkyl substances (PFAS) are increasingly recognized as environmental contaminants of concern, due to their pervasive presence in various ecosystems and potential health impacts. As governments, industries, and communities grapple with the challenges posed by these “forever chemicals,” the role of PFAS testing labs has become paramount. Whether you’re a municipal director responsible for clean water compliance, a design engineer developing innovative solutions, or a plant operator seeking to ensure safety, understanding the significance of PFAS testing labs is crucial in addressing one of the most pressing environmental issues of our time.
Laboratory analysis is one component of the wider PFAS Testing & Analysis discipline, which spans field sampling, screening, bench and pilot verification, and the confirmatory laboratory work described here. The distinction matters commercially: a screening result and a confirmatory result carry very different evidentiary weight, cost very different amounts, and are appropriate at very different points in an investigation. Understanding which is which prevents both over-specification and the far more expensive error of building a case on data that will not survive scrutiny.
PFAS are a group of synthetic chemicals characterized by a chain of carbon atoms surrounded by fluorine atoms, which grants them unique properties such as water and oil repellency. Their industrial applications range from non-stick cookware to firefighting foam and water-resistant textiles.
According to the Environmental Protection Agency (EPA), sources of PFAS contamination are diverse and include:
Emerging studies have linked PFAS exposure to various health issues including:
As of July 2025, the EPA has implemented stricter regulations governing PFAS. The newly standardized drinking water contaminants and necessary reporting requirements urge water suppliers to routinely monitor for PFAS, further emphasizing the critical need for reliable PFAS testing labs.
PFAS testing labs serve a vital function in mitigating the risks associated with PFAS contamination. Their primary roles include:
PFAS testing labs employ various methodologies to detect and quantify PFAS, including:
In 2024, advancements in technology have led to more efficient and precise testing methods, further enhancing the reliability of PFAS testing.
Choosing a certified lab ensures compliance with regulatory standards. The EPA’s Methods 533 and 537.1 are commonly adopted protocols for PFAS testing, offering an added layer of reliability and credibility.
When selecting a PFAS testing lab, municipal directors, engineers, and plant operators should consider the following:
Aventura, a city grappling with PFAS in its water supply, partnered with a certified PFAS testing lab to monitor levels and develop a robust response strategy. Regular monitoring has led to timely remediation efforts, including updated filtration systems that have decreased PFAS levels by over 90%.
An aerospace manufacturer facing scrutiny for PFAS in wastewater utilized a PFAS testing lab to analyze runoff. Results were pivotal in altering industrial processes and greatly reducing the environmental footprint.
Innovations in water treatment technologies are critical in addressing PFAS contamination effectively. Techniques such as:
With continuous advancements in science and technology, the future of PFAS remediation appears promising. Research into bio-remediation techniques and the development of PFAS-specific adsorbents aims to provide more effective solutions.
Laboratories do not offer one PFAS test. They offer a family of methods that differ in analyte coverage, matrix applicability, reporting limits, and legal defensibility, and the choice among them is the most consequential decision in a monitoring programme. The subsections below cover the principal methods and the pages that treat each in depth.
All routine PFAS quantification is targeted: the laboratory measures a defined list of compounds against authentic standards and reports each one. Nothing outside that list is reported, whether or not it is present. Our dedicated coverage of PFAS analytical methods works through the instrumentation and sample preparation chain that underpins every method in this family — solid phase extraction, liquid chromatography separation, tandem mass spectrometry detection, and the isotope dilution or internal standard approaches used for quantification. It also addresses the practical consequences of the targeted approach: branched and linear isomer reporting conventions, the difference between a method detection limit and a reporting limit, and why two laboratories running the same nominal method can return results that differ by a factor of two at low concentrations.
The first widely adopted drinking water method, EPA Method 537.1 covers 18 PFAS in finished drinking water using solid phase extraction on a polystyrenedivinylbenzene cartridge followed by LC/MS/MS with surrogate-based quantification. It remains the most widely accredited method and the one most laboratories can deliver at the shortest turnaround. Its limitations are specific and worth understanding before selecting it: it does not cover several short-chain compounds now of regulatory interest, its recovery for certain replacement chemistries is poor, and its surrogate-based quantification is more susceptible to matrix effects than isotope dilution. It applies to drinking water only — using it on wastewater, leachate, or groundwater with significant matrix is outside its scope.
Developed to close the short-chain gap, EPA Method 533 covers 25 PFAS in drinking water using isotope dilution quantification, which corrects for matrix effects and extraction losses on a compound-by-compound basis rather than through a surrogate. Its analyte list emphasises shorter-chain compounds and the ether carboxylic acid replacement chemistries, and it generally achieves lower and more reproducible reporting limits than 537.1. The two methods overlap but are not interchangeable: several compounds appear on only one list, which is why compliance monitoring under the drinking water rule permits either and many programmes run both. When a monitoring plan is being written, the analyte list — not the method number — is what should be specified.
Neither 537.1 nor 533 applies outside drinking water, which left a substantial gap for wastewater, biosolids, soil, sediment, leachate, and tissue. EPA Method 1633 addresses it, covering 40 PFAS across those matrices with isotope dilution quantification and matrix-specific preparation procedures. Any utility characterising influent, effluent, or biosolids, and any industrial discharger operating under a pretreatment programme, will be working to 1633 rather than to the drinking water methods. Confirm that a prospective laboratory holds accreditation for 1633 in the specific matrix required, since accreditation is granted per matrix and a laboratory competent in aqueous samples may not be accredited for solids.
Confirmatory analysis is expensive and slow, which creates real demand for faster and cheaper preliminary work. PFAS screening methods occupy that space, and our dedicated page covers total oxidisable precursor screening, adsorbable and extractable organic fluorine, particle-induced gamma ray emission, combustion ion chromatography, and the emerging field-portable sensor technologies. The correct use of screening is to allocate confirmatory sampling effort intelligently — to decide which of forty wells warrants a full analysis, or to establish whether an unattributed fluorine mass exists at all. The incorrect use is to treat a screening result as a compliance datum. Screening results are generally not defensible for enforcement, permitting, or litigation, and a programme that blurs the distinction will eventually have to repeat the work.
The total oxidizable precursor assay addresses the single largest blind spot in targeted analysis. Many real samples — particularly those affected by aqueous film-forming foam or industrial discharge — carry a substantial mass of polyfluorinated precursors that no targeted method reports but that will oxidise over time in the environment into the terminal perfluoroalkyl acids that are actually regulated. The assay applies a strong chemical oxidation step under alkaline conditions to convert those precursors to measurable end products, then quantifies the difference between pre-oxidation and post-oxidation results. That difference is the precursor mass. A site whose targeted results sit comfortably below action levels but whose precursor mass is large does not have a clean result; it has a deferred one.
PFOS and several other compounds occur as mixtures of linear and branched isomers, and laboratories differ in how they handle them. Some report linear and branched fractions separately, some sum them, and some quantify branched isomers against a linear standard, which introduces a systematic bias that can run to tens of percent. None of these approaches is wrong, but they are not comparable, and a dataset assembled from laboratories using different conventions cannot support a trend analysis. The convention should be fixed in the specification and stated on every report. The same applies to the treatment of results between the method detection limit and the reporting limit — whether they are reported as estimated values with a qualifier or simply as non-detects materially changes how a low-level dataset reads, and it is a question of laboratory policy rather than of method.
The table below compares the principal methods against the criteria that decide a selection. Note that the assay discussed above is commonly referred to by its abbreviation in laboratory quotations and reports, and the practical mechanics of ordering, interpreting, and budgeting for it are covered separately under TOP assay, which addresses turnaround expectations, the oxidation conditions used by different laboratories, and how to read the pre- and post-oxidation delta.
| Method | Matrix | Analytes | Quantification | Best Use | Defensibility |
|---|---|---|---|---|---|
| EPA Method 537.1 | Finished drinking water only | 18 PFAS | Surrogate-based | Routine compliance monitoring; widest accreditation; shortest turnaround | High — compliance defensible |
| EPA Method 533 | Drinking water | 25 PFAS, short-chain emphasis | Isotope dilution | Where short-chain and replacement chemistries matter | High — compliance defensible |
| EPA Method 1633 | Wastewater, groundwater, soil, biosolids, sediment, leachate, tissue | 40 PFAS | Isotope dilution | Non-potable matrices; NPDES and pretreatment work; biosolids | High — accreditation is per matrix |
| Total oxidizable precursor assay | Aqueous, soil | Precursor mass by difference | Pre- and post-oxidation delta | AFFF and industrial sites; estimating deferred liability | Investigative — not a compliance datum |
| Total organic fluorine (AOF, EOF, CIC) | Aqueous, solids | Total fluorine mass | Combustion ion chromatography | Closing a fluorine mass balance; destruction verification | Investigative |
| Field-portable screening | Aqueous | Indicative only | Sensor or colourimetric | Prioritising confirmatory sampling across many locations | Low — screening only |
Selecting a laboratory is a procurement exercise with unusually technical acceptance criteria. Working through the sequence below in order prevents the common outcome of a dataset that cost a great deal and cannot be used.
Begin by naming every compound that must be reported and every matrix that will be sampled, then let the method follow. A specification written as “PFAS analysis by EPA method” is not a specification, because the compound lists differ materially between methods and the matrix determines which are even applicable. State the required reporting limit for each compound as well, since a laboratory can satisfy a method requirement while reporting limits well above the action level the programme is measuring against.
Accreditation under a recognised programme is granted for a specific method in a specific matrix. A laboratory accredited for 537.1 in drinking water is not thereby accredited for 1633 in biosolids, and the distinction is routinely glossed over in marketing material. Request the current scope of accreditation document rather than accepting a general claim, confirm the expiry date, and confirm that the accrediting body is recognised by the relevant state primacy agency.
Agree the deliverable in advance: field, trip, and equipment blank handling, matrix spike and duplicate frequency, surrogate and internal standard recovery acceptance windows, isomer reporting convention, and whether raw data and chromatograms will be supplied. Establish how the laboratory will report a blank detection and what happens to the affected batch. These terms are cheap to negotiate before award and effectively impossible afterwards.
Analytical quality is capped by sample quality, and PFAS sampling has an unusually long list of prohibitions and a correspondingly high failure rate. The laboratory should supply the bottles, the preservation instructions, and the field documentation, and should be consulted on the sampling plan rather than handed the results of one. Programmes extending beyond aqueous samples into soil, sediment, or biosolids should also review our coverage of PFAS field testing, which addresses solid-matrix sampling design, depth profiling, and the field decontamination procedures that determine whether a solids dataset means anything.
Monitoring programmes generate value through trend, and trend requires comparability. Fix the laboratory, the method, the analyte list, and the reporting limits at the outset and hold all four constant. Changing laboratories mid-programme, or accepting an upgrade from 537.1 to 533, introduces a step change in the data that cannot be reliably distinguished from a real change in the water. Where a change is unavoidable, run a parallel period on both configurations so the offset can be characterised rather than guessed at.
Ask for the reporting limit per compound in writing before you award, and check it against the action level you actually have to defend. A laboratory quoting an attractive price frequently achieves it with reporting limits above the regulatory threshold, which produces a page of non-detects that prove nothing. A non-detect at a reporting limit of 20 nanograms per litre tells you nothing at all about compliance with a 4 nanogram per litre limit.
Five recur. Specifying a method number instead of an analyte list and a matrix. Accepting a general accreditation claim without the scope document. Omitting the reporting limit requirement, then discovering the results cannot address the question. Treating a screening result as a compliance datum, which usually surfaces only when the result is challenged. And sampling before the laboratory has been engaged, so that bottles, preservation, and blank protocol are all improvised in the field. None of these is expensive to avoid; all of them are expensive to correct, because the remedy is always to resample.
Storing only the summed PFAS value from historical rounds. Compound distribution — particularly the long-chain to short-chain ratio — is what predicts carbon and resin bed life and drives the entire treatment technology decision. A utility that retained only a summed figure cannot reconstruct that ratio when the treatment decision arrives, and will pay to resample water it already analysed. Retain the full analyte-level dataset from every round, including compounds that are not currently regulated.
Two interpretation errors dominate. The first is treating a detection in a field or equipment blank as a nuisance rather than as an invalidation of that batch — ambient PFAS contamination in field materials readily exceeds the concentrations being measured, so a positive blank means the associated results cannot be relied on. The second is comparing results across rounds without checking that reporting limits were identical; an apparent improvement is frequently a change in reporting limit rather than a change in the water. Read the case narrative and the quality control summary, not only the results table.
Compliance monitoring for PFAS in public drinking water arises under the Safe Drinking Water Act through the National Primary Drinking Water Regulation finalised for PFAS in April 2024, which established enforceable maximum contaminant levels for PFOA and PFOS together with limits and a Hazard Index approach for several additional compounds. Elements of that rule, including the compliance schedule and the treatment of the compounds beyond PFOA and PFOS, have been subject to subsequent agency reconsideration and litigation, so the operative monitoring requirement and schedule should be confirmed against the current Federal Register text and the state primacy agency. Approved analytical methods for that monitoring are EPA Methods 537.1 and 533. Non-potable monitoring arises under the Clean Water Act through NPDES permits and pretreatment programmes, using EPA Method 1633. The CERCLA hazardous substance designation for PFOA and PFOS creates separate reporting obligations for which data defensibility standards are correspondingly higher. Many states have adopted standards more stringent than the federal values or require additional analytes, so the state requirement should be checked in every case.
Both are drinking water methods approved for compliance monitoring, but they differ in coverage and quantification. Method 537.1 covers 18 PFAS using surrogate-based quantification; Method 533 covers 25 with an emphasis on shorter-chain compounds and replacement chemistries, and uses isotope dilution, which corrects for matrix effects compound by compound and generally yields lower, more reproducible reporting limits. The analyte lists overlap but are not identical, which is why many programmes run both rather than choosing between them.
Methods 537.1 and 533 were validated for finished drinking water, a comparatively clean matrix. Wastewater, leachate, soil, sediment, and biosolids introduce interferences, competing organics, and extraction difficulties that those methods were never designed to handle, so results from them in those matrices are not defensible. EPA Method 1633 exists specifically to cover the non-potable matrices, and laboratory accreditation for it is granted per matrix rather than in general.
Costs vary widely by method, matrix, analyte count, and turnaround. Confirmatory drinking water analysis is typically the least expensive per sample; non-potable matrices under Method 1633 cost substantially more because of the preparation burden; precursor and total fluorine work adds further cost. Standard turnaround is commonly two to four weeks, with expedited options available at a premium. Because laboratory capacity for PFAS has been tight, commit turnaround contractually rather than assuming it, particularly around regulatory deadlines.
Generally no. Screening approaches are designed to be fast and inexpensive, and they trade defensibility for that speed. They are valuable for prioritising where confirmatory samples should be taken and for establishing whether unattributed fluorine mass exists, but they are not appropriate for enforcement, permitting, or litigation. Any result that will be defended should come from an accredited laboratory running an approved method for the matrix in question.
It quantifies what targeted analysis cannot see. Polyfluorinated precursors present in many samples are not reported by any targeted method, but they transform in the environment into the regulated terminal compounds. The assay oxidises them and reports the difference before and after, which is the precursor mass. It is most valuable at sites with AFFF or industrial history, where a large precursor mass means today’s comfortable result understates tomorrow’s liability.
Several legitimate reasons, and one avoidable one. Legitimate differences arise from different methods with different analyte lists, different reporting limits, different isomer reporting conventions, and different quantification approaches. Near the reporting limit, variability of a factor of two between laboratories is not unusual. The avoidable cause is sample-side: field contamination, inconsistent preservation, or holding time exceedance. Split-sample comparison between laboratories is a reasonable diagnostic, but it should be designed with both laboratories informed rather than run as an audit.
That depends on what the programme has to demonstrate. Establishing whether a problem exists can be done with a small number of well-placed samples supported by screening. Establishing a defensible baseline for a compliance or liability position requires enough rounds to characterise seasonal and operational variability, which generally means quarterly sampling across at least a full year before any trend claim is credible. Source investigation is different again and is driven by hydrogeology rather than by a schedule. Design the programme around the question being answered rather than around a default sampling frequency, and budget for the resamples that blank failures and holding time exceedances will inevitably require.
Either can work, but the decision should be deliberate. Laboratory-performed sampling costs more per round and transfers responsibility for field protocol and blank handling to a party that understands the failure modes, which is worth a great deal on a first round or a legally sensitive investigation. In-house sampling is substantially cheaper and appropriate for routine monitoring once staff have been trained on the prohibited-materials list and the blank regime and the protocol has been documented. The worst arrangement is in-house sampling without training, which produces a dataset that looks complete and fails when examined.
In a world that increasingly recognizes the risks posed by PFAS, the role of PFAS testing labs cannot be overstated. They serve as the frontline defense against contamination, enabling effective monitoring and remediation strategies. As you navigate the complexities of PFAS regulations and seek to ensure safe water for your community or facility, partnering with a reliable PFAS testing lab is not just a recommendation; it is an essential prerequisite for responsible environmental stewardship.
By equipping yourself with knowledge and working with accredited labs, stakeholders can effectively address PFAS-related challenges and contribute to a cleaner, safer, and healthier environment for all. As we look toward future innovations and regulatory standards, understanding the importance of PFAS testing will remain a cornerstone of effective environmental management.